RS51136B - Supstituisani pirolopiridini, kompozicije koje ih sadrže, postupak za njihovo dobijanje i upotreba - Google Patents

Supstituisani pirolopiridini, kompozicije koje ih sadrže, postupak za njihovo dobijanje i upotreba

Info

Publication number
RS51136B
RS51136B RSP-2009/0400A RSP20090400A RS51136B RS 51136 B RS51136 B RS 51136B RS P20090400 A RSP20090400 A RS P20090400A RS 51136 B RS51136 B RS 51136B
Authority
RS
Serbia
Prior art keywords
pyridines
producing
composition containing
substituted pyrrolo
substituted
Prior art date
Application number
RSP-2009/0400A
Other languages
English (en)
Inventor
Baptiste Ronan
Catherine Souaille
Fabrice Viviani
Eric Bacque
Pascal Desmazeau
Frank Halley
Michel Tabart
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of RS51136B publication Critical patent/RS51136B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Proizvodi formule (I):gde:1) A i Ar su supstituisane fenil grupe; 2)L je NH-CO-NH;3) W je C(R6), jedan od Y i Z je odabran od N i NO, a drugi je C(R5);4) R1, R5, i R6 su H;5) Ra je H.Prijava sadrži još 17 patentnih zahteva.
RSP-2009/0400A 2005-04-26 2006-04-26 Supstituisani pirolopiridini, kompozicije koje ih sadrže, postupak za njihovo dobijanje i upotreba RS51136B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0504173A FR2884821B1 (fr) 2005-04-26 2005-04-26 Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
PCT/FR2006/000925 WO2006114520A2 (fr) 2005-04-26 2006-04-26 Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
RS51136B true RS51136B (sr) 2010-10-31

Family

ID=35517344

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2009/0400A RS51136B (sr) 2005-04-26 2006-04-26 Supstituisani pirolopiridini, kompozicije koje ih sadrže, postupak za njihovo dobijanje i upotreba

Country Status (33)

Country Link
US (1) US7947706B2 (sr)
EP (1) EP1877409B1 (sr)
JP (1) JP2008539211A (sr)
KR (1) KR20080007229A (sr)
CN (1) CN101166739A (sr)
AR (1) AR061386A1 (sr)
AT (1) ATE433976T1 (sr)
AU (1) AU2006239105A1 (sr)
BR (1) BRPI0613161A2 (sr)
CA (1) CA2605744A1 (sr)
CR (1) CR9463A (sr)
CY (1) CY1109369T1 (sr)
DE (1) DE602006007337D1 (sr)
DK (1) DK1877409T3 (sr)
DO (1) DOP2006000096A (sr)
EA (1) EA012983B1 (sr)
ES (1) ES2328629T3 (sr)
FR (1) FR2884821B1 (sr)
GT (1) GT200600174A (sr)
HR (1) HRP20090494T1 (sr)
IL (1) IL186523A0 (sr)
MA (1) MA29480B1 (sr)
MX (1) MX2007013084A (sr)
NO (1) NO20075918L (sr)
PA (1) PA8671301A1 (sr)
PE (1) PE20071420A1 (sr)
PL (1) PL1877409T3 (sr)
PT (1) PT1877409E (sr)
RS (1) RS51136B (sr)
SI (1) SI1877409T1 (sr)
TN (1) TNSN07360A1 (sr)
TW (1) TW200718701A (sr)
WO (1) WO2006114520A2 (sr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
US20100120717A1 (en) * 2006-10-09 2010-05-13 Brown Jason W Kinase inhibitors
JP2010505961A (ja) * 2006-10-09 2010-02-25 タケダ サン ディエゴ インコーポレイテッド キナーゼ阻害剤
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
JP5442449B2 (ja) 2006-12-22 2014-03-12 アステックス、セラピューティックス、リミテッド 新規化合物
WO2008078091A1 (en) * 2006-12-22 2008-07-03 Astex Therapeutics Limited Bicyclic heterocyclic compounds as fgfr inhibitors
EP2170830B1 (en) 2007-07-17 2014-10-15 Plexxikon, Inc. 2-FLUORO-BENZENESULFONAMIDE COMPOUNDS AS Raf KINASE MODULATORS
GB0720038D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
GB0720041D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
DE102008052943A1 (de) 2008-10-23 2010-04-29 Merck Patent Gmbh Azaindolderivate
ES2552386T3 (es) 2009-04-03 2015-11-27 F. Hoffmann-La Roche Ag Composiciones de {3-[5-(4-cloro-fenil)-1H-pirrol[2,3-b]piridin-3-carbonil]-2,4-difluoro-fenil}-amida del ácido propano-1-sulfónico y usos de las mismas
GB0906472D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
GB0906470D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
US20110030037A1 (en) * 2009-07-07 2011-02-03 Vadim Olshansky Zone migration in network access
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
EA201290210A1 (ru) 2009-11-06 2012-10-30 Плексксикон, Инк. Соединения и способы модуляции киназы и показания для их применения
SMT201900112T1 (it) 2011-02-07 2019-02-28 Plexxikon Inc Composti e metodi per la modulazione della chinasi, e indicazioni corrispettive
AR085279A1 (es) 2011-02-21 2013-09-18 Plexxikon Inc Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
EP2855477A4 (en) * 2012-05-29 2015-11-18 Merck Sharp & Dohme ISOTOPICALLY MARKED BIARYL UREA COMPOUNDS
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
US20140275082A1 (en) 2013-03-14 2014-09-18 Abbvie Inc. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
GB201310460D0 (en) * 2013-06-12 2013-07-24 Lytix Biopharma As Compounds
GB201310464D0 (en) * 2013-06-12 2013-07-24 Lytix Biopharma As Compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3254843B2 (ja) * 1993-08-09 2002-02-12 三菱ウェルファーマ株式会社 新規縮合ヘテロ環誘導体
US6335342B1 (en) * 2000-06-19 2002-01-01 Pharmacia & Upjohn S.P.A. Azaindole derivatives, process for their preparation, and their use as antitumor agents
GB0115109D0 (en) 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
JP2005508904A (ja) * 2001-09-11 2005-04-07 スミスクライン ビーチャム コーポレーション 血管新生阻害剤としてのフロ−及びチエノピリミジン誘導体
WO2003028724A1 (en) * 2001-10-04 2003-04-10 Smithkline Beecham Corporation Chk1 kinase inhibitors
CA2464214C (en) * 2001-10-22 2011-02-08 The Research Foundation Of State University Of New York Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
ATE374200T1 (de) * 2002-03-28 2007-10-15 Eisai R&D Man Co Ltd 7-azaindole als inhibitoren c-jun n-terminaler kinasen zur behandlung neurodegenerativer störungen
FR2878849B1 (fr) 2004-12-06 2008-09-12 Aventis Pharma Sa Indoles substitues, compositions les contenant, procede de fabrication et utilisation

Also Published As

Publication number Publication date
AR061386A1 (es) 2008-08-27
CA2605744A1 (fr) 2006-11-02
MA29480B1 (fr) 2008-05-02
AU2006239105A1 (en) 2006-11-02
KR20080007229A (ko) 2008-01-17
PA8671301A1 (es) 2006-12-07
CY1109369T1 (el) 2014-07-02
WO2006114520A3 (fr) 2007-03-01
EA200702329A1 (ru) 2008-02-28
DE602006007337D1 (de) 2009-07-30
ATE433976T1 (de) 2009-07-15
FR2884821A1 (fr) 2006-10-27
SI1877409T1 (sl) 2009-12-31
HRP20090494T1 (hr) 2009-10-31
GT200600174A (es) 2006-12-26
DK1877409T3 (da) 2009-10-05
EP1877409A2 (fr) 2008-01-16
MX2007013084A (es) 2008-01-11
CR9463A (es) 2008-02-21
NO20075918L (no) 2007-11-19
JP2008539211A (ja) 2008-11-13
IL186523A0 (en) 2008-01-20
US20080139606A1 (en) 2008-06-12
CN101166739A (zh) 2008-04-23
EA012983B1 (ru) 2010-02-26
DOP2006000096A (es) 2007-04-15
PL1877409T3 (pl) 2009-12-31
TNSN07360A1 (en) 2008-12-31
EP1877409B1 (fr) 2009-06-17
FR2884821B1 (fr) 2007-07-06
US7947706B2 (en) 2011-05-24
WO2006114520A2 (fr) 2006-11-02
PT1877409E (pt) 2009-09-16
TW200718701A (en) 2007-05-16
ES2328629T3 (es) 2009-11-16
PE20071420A1 (es) 2007-01-20
BRPI0613161A2 (pt) 2010-12-21

Similar Documents

Publication Publication Date Title
RS51136B (sr) Supstituisani pirolopiridini, kompozicije koje ih sadrže, postupak za njihovo dobijanje i upotreba
RS115004A (en) Novel thiophenylglycoside derivatives,methods for production thereof, medicaments comprising said compounds and use thereof
RS52042B (sr) Fungicidne smeše
ATE433447T1 (de) Pyrimiidinverbindungen
BR0307432A (pt) Difluormetiltiazolilcarboxanilidas
ATE338461T1 (de) Pyrazolpyrimidinfungizide
MX2007012090A (es) Derivados sustituidos de pirazoliloxifenilo como herbicidas.
UA98116C2 (ru) Изоксазолины, композиция, их применение, способы получения и промежуточные соединения
CY1109854T1 (el) Παραγωγα αζαδικυκλο(3.1.0)εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
AR091405A2 (es) Omega-carboxiaril difenil urea sustituida con fluoro y composiciones farmaceuticas que las contienen
MXPA04000622A (es) Pirazolilcarboxanilidas como funguicidas.
SE0102616D0 (sv) Novel compounds
TNSN04199A1 (en) Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
MXPA05009969A (es) Metodo para aislar la forma cristalina i de la 5-azacitidina.
MY157871A (en) Mapk/erk kinase inhibitors
NO20070089L (no) DPP-IV inhibitorer
CY1110034T1 (el) Παραγωγα 1,2,4,5-τετραϋδρο-3h-βενζαζεπινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν
RS51661B (sr) Novi derivati diosmetina, postupak za njihovu izradu i farmaceutske smeše koje ih sadrže
GEP20115166B (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
HRP20050359B1 (hr) Novi postupak za industrijsku sintezu stroncij renalata i njegovih hidrata
RS53211B (sr) DERIVATI PIRIDO[2,3-d]PIRIMIDINA, NJIHOVO DOBIJANJE, NJIHOVA PRIMENA U TERAPIJI
SE0300092D0 (sv) Novel compounds
SE0300091D0 (sv) Novel compounds